Copyright Reports & Markets. All rights reserved.

Global Nanomedicine Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Nanomedicine Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Quantum dots
      • 1.4.3 Nanoparticles
      • 1.4.4 Nanoshells
      • 1.4.5 Nanotubes
      • 1.4.6 Nanodevices
    • 1.5 Market by Application
      • 1.5.1 Global Nanomedicine Market Share by Application (2014-2025)
      • 1.5.2 Segmentation encompasses oncology
      • 1.5.3 Infectious diseases
      • 1.5.4 Cardiology
      • 1.5.5 Orthopedics
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Nanomedicine Market Size
    • 2.2 Nanomedicine Growth Trends by Regions
      • 2.2.1 Nanomedicine Market Size by Regions (2014-2025)
      • 2.2.2 Nanomedicine Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Nanomedicine Market Size by Manufacturers
      • 3.1.1 Global Nanomedicine Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Nanomedicine Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Nanomedicine Market Concentration Ratio (CR5 and HHI)
    • 3.2 Nanomedicine Key Players Head office and Area Served
    • 3.3 Key Players Nanomedicine Product/Solution/Service
    • 3.4 Date of Enter into Nanomedicine Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Nanomedicine Market Size by Type (2014-2019)
    • 4.2 Global Nanomedicine Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Nanomedicine Market Size (2014-2019)
    • 5.2 Nanomedicine Key Players in United States
    • 5.3 United States Nanomedicine Market Size by Type
    • 5.4 United States Nanomedicine Market Size by Application

    6 Europe

    • 6.1 Europe Nanomedicine Market Size (2014-2019)
    • 6.2 Nanomedicine Key Players in Europe
    • 6.3 Europe Nanomedicine Market Size by Type
    • 6.4 Europe Nanomedicine Market Size by Application

    7 China

    • 7.1 China Nanomedicine Market Size (2014-2019)
    • 7.2 Nanomedicine Key Players in China
    • 7.3 China Nanomedicine Market Size by Type
    • 7.4 China Nanomedicine Market Size by Application

    8 Japan

    • 8.1 Japan Nanomedicine Market Size (2014-2019)
    • 8.2 Nanomedicine Key Players in Japan
    • 8.3 Japan Nanomedicine Market Size by Type
    • 8.4 Japan Nanomedicine Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Nanomedicine Market Size (2014-2019)
    • 9.2 Nanomedicine Key Players in Southeast Asia
    • 9.3 Southeast Asia Nanomedicine Market Size by Type
    • 9.4 Southeast Asia Nanomedicine Market Size by Application

    10 India

    • 10.1 India Nanomedicine Market Size (2014-2019)
    • 10.2 Nanomedicine Key Players in India
    • 10.3 India Nanomedicine Market Size by Type
    • 10.4 India Nanomedicine Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Nanomedicine Market Size (2014-2019)
    • 11.2 Nanomedicine Key Players in Central & South America
    • 11.3 Central & South America Nanomedicine Market Size by Type
    • 11.4 Central & South America Nanomedicine Market Size by Application

    12 International Players Profiles

    • 12.1 Combimatrix
      • 12.1.1 Combimatrix Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Nanomedicine Introduction
      • 12.1.4 Combimatrix Revenue in Nanomedicine Business (2014-2019)
      • 12.1.5 Combimatrix Recent Development
    • 12.2 Ablynx
      • 12.2.1 Ablynx Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Nanomedicine Introduction
      • 12.2.4 Ablynx Revenue in Nanomedicine Business (2014-2019)
      • 12.2.5 Ablynx Recent Development
    • 12.3 Abraxis Bioscience
      • 12.3.1 Abraxis Bioscience Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Nanomedicine Introduction
      • 12.3.4 Abraxis Bioscience Revenue in Nanomedicine Business (2014-2019)
      • 12.3.5 Abraxis Bioscience Recent Development
    • 12.4 Celgene
      • 12.4.1 Celgene Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Nanomedicine Introduction
      • 12.4.4 Celgene Revenue in Nanomedicine Business (2014-2019)
      • 12.4.5 Celgene Recent Development
    • 12.5 Mallinckrodt
      • 12.5.1 Mallinckrodt Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Nanomedicine Introduction
      • 12.5.4 Mallinckrodt Revenue in Nanomedicine Business (2014-2019)
      • 12.5.5 Mallinckrodt Recent Development
    • 12.6 Arrowhead Research
      • 12.6.1 Arrowhead Research Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Nanomedicine Introduction
      • 12.6.4 Arrowhead Research Revenue in Nanomedicine Business (2014-2019)
      • 12.6.5 Arrowhead Research Recent Development
    • 12.7 GE Healthcare
      • 12.7.1 GE Healthcare Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Nanomedicine Introduction
      • 12.7.4 GE Healthcare Revenue in Nanomedicine Business (2014-2019)
      • 12.7.5 GE Healthcare Recent Development
    • 12.8 Merck
      • 12.8.1 Merck Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Nanomedicine Introduction
      • 12.8.4 Merck Revenue in Nanomedicine Business (2014-2019)
      • 12.8.5 Merck Recent Development
    • 12.9 Pfizer
      • 12.9.1 Pfizer Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Nanomedicine Introduction
      • 12.9.4 Pfizer Revenue in Nanomedicine Business (2014-2019)
      • 12.9.5 Pfizer Recent Development
    • 12.10 Nanosphere
      • 12.10.1 Nanosphere Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Nanomedicine Introduction
      • 12.10.4 Nanosphere Revenue in Nanomedicine Business (2014-2019)
      • 12.10.5 Nanosphere Recent Development
    • 12.11 Epeius Biotechnologies
    • 12.12 Cytimmune Sciences
    • 12.13 Nanospectra Biosciences

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Nanomedicine is the medical application of nanotechnology.Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines.
      As per the WHO factsheet, cancer is found to be one of the major causes of mortality and morbidity worldwide, with approximately 14 million new cases in 2012 and 8.2 million cancer-related deaths. Thus, demand for nanomedicine in order to curb such high incidence rate is expected to boost market progress during the forecast period.
      Potential pipeline of products based on the nanomolecules and associated technologies are anticipated to drive market with potential avenues of growth. Presence of around 40% of products in phase II of clinical development, is anticipated to result in a number of key commercialization over the coming decade influencing revenue generation over the forecast period. The customized treatment options available for eradication of genetic abnormalities also makes this technology a substantial option for precision medicine.
      Asia Pacific is expected to witness lucrative growth through to 2025 as a result of rise in number of research grants and increase in demand for prophylaxis of life-threatening diseases. Moreover, rise in the number of venture capital investors from developing economies of this region and increasing international research collaborations are anticipated to propel growth in nanotechnology-based healthcare industry.
      In 2018, the global Nanomedicine market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Nanomedicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nanomedicine development in United States, Europe and China.

      The key players covered in this study
      Combimatrix
      Ablynx
      Abraxis Bioscience
      Celgene
      Mallinckrodt
      Arrowhead Research
      GE Healthcare
      Merck
      Pfizer
      Nanosphere
      Epeius Biotechnologies
      Cytimmune Sciences
      Nanospectra Biosciences

      Market segment by Type, the product can be split into
      Quantum dots
      Nanoparticles
      Nanoshells
      Nanotubes
      Nanodevices

      Market segment by Application, split into
      Segmentation encompasses oncology
      Infectious diseases
      Cardiology
      Orthopedics
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Nanomedicine status, future forecast, growth opportunity, key market and key players.
      To present the Nanomedicine development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Nanomedicine are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now